A clinical-stage biotech in developing novel, best-in-class therapeutics for inflammation and oncology
Fully-integrated therapeutic antibody-based discovery and development capabilities and know-how to develop emerging technology platforms.
A differentiated product pipeline for both novel and validated targets of targeted therapy.
Opening to opportunities worldwide to co-develop our therapeutic products and proprietary technology platform with strategic partners.
An experienced management team and unique corporate culture focusing on innovation and fostering a highly teamwork-orientated environment.Learn more